CN103565811A - Compound vitamin lyophilized preparation for injection and its preparation method - Google Patents

Compound vitamin lyophilized preparation for injection and its preparation method Download PDF

Info

Publication number
CN103565811A
CN103565811A CN201210248472.XA CN201210248472A CN103565811A CN 103565811 A CN103565811 A CN 103565811A CN 201210248472 A CN201210248472 A CN 201210248472A CN 103565811 A CN103565811 A CN 103565811A
Authority
CN
China
Prior art keywords
vitamin
injection
heating rate
preparation
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210248472.XA
Other languages
Chinese (zh)
Other versions
CN103565811B (en
Inventor
夏彤
何庆国
韩盼盼
张云升
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Ideal & Hightech Pharmaceutical Co., Ltd.
Original Assignee
HEBEI ZHITONG PHARMACEUTICAL GROUP CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEBEI ZHITONG PHARMACEUTICAL GROUP CO Ltd filed Critical HEBEI ZHITONG PHARMACEUTICAL GROUP CO Ltd
Priority to CN201210248472.XA priority Critical patent/CN103565811B/en
Publication of CN103565811A publication Critical patent/CN103565811A/en
Application granted granted Critical
Publication of CN103565811B publication Critical patent/CN103565811B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a compound vitamin lyophilized preparation for injection and its preparation method. According to the invention, a scientific prescription and preparation process are utilized to make the prepared compound vitamin lyophilized preparation for injection have the advantages of high stability, low impurity content and the like.

Description

A kind of composite vitamin for injection lyophilized formulations and preparation method thereof
Technical field
The present invention relates to pharmaceutical field, be specifically related to a kind of composite vitamin for injection lyophilized formulations and preparation method thereof.
Background technology
Parenteral alimentation is comprised of carbohydrate, aminoacid, fat milk, electrolyte, vitamin, trace element and the required nutritional factors of water seven large body, directly inputs the injection of body in the mode of periphery or central vein intubate.Seven large nutritional factorss have been mixed in proportion very important meaning, can play to critical patient the effect that maintains, extends and save life, the patient of normal feed or superelevation metabolism be played and correct negative nitrogen balance, promote wound healing, the effect of putting on weight and improving survival rate.
Water soluble vitamins comprises vitamin C and vitamin B group, is to maintain the necessary nutrient substance of normal physiological activity, participates in the homergy of tissue and cell; Meanwhile, water soluble vitamins is in body, to be difficult to one group of compound synthetic and that store, must from food, obtain by quantitative timing.Although normal human's demand is very micro-, Deficiency of Intake just can cause various diseases.It is global nutritional problem that water soluble vitamins lacks.Vitimin supplement is the important content of parenteral alimentation, is also the important component part of intravenous nutrition.
Vitamin B 1(thiamine hydrochloride) exists with sequestered in human plasma, in liver, by pyrophosphorylation, become pyrophosphate, i.e. cocarboxylase (TPP).Tricarboxylic acid cycle in the aerobic oxidation metabolic process of TPP involved in sugar in human body.When Vitamin B1 deficiency, cocarboxylase cannot form, thereby tricarboxylic acid cycle is obstructed, and carbohydrate metabolism can not normally be carried out.Vitamin B 1easily excrete, do not pile up intoxicating phenomenon.Only, when intravenous injection, occasionally there are medicine heat and anaphylaxis.
Vitamin B 2(riboflavin) is one of composition of respiratory chain, is the coenzyme of the flavo-enzymes such as flavin adenine (FAD) and flavin mononucleotide (FMN) (FMN), participates in the transmission of hydrogen in biological oxidation process.If there is no vitamin B 2, biological oxidation process can not be carried out smoothly.Vitamin B 2the somatic normal growth of participant also.Use vitamin B 2the normal yellow of discharging is urinated, but has no adverse reaction.
Vitamin C (ascorbic acid) is easily oxidized, participates in the transmission of hydrogen, participates in organism redox reaction, in Cellular respiration process, plays an important role.Vitamin C is also participated in the synthetic of lysine and proline hydroxylase, and these enzymes are to maintain the necessary material of collagen fiber normal configuration, therefore the C that is deficient in vitamin can cause vitamin C deficiency.Vitamin C also has antagonism radical damage, improves body's immunity, check melanin nucleus formation, and participates in iron metabolism, has the effect of protection hemoglobin.
1985, Japan Fuso Pharmaceuticals Industries, Ltd. has developed compound vitamin (3) injection, be mainly used in vitamin supply, in the time of cannot fully absorbing by food at a large amount of vitimin supplement of needs, use, as wasting diseases, gravid woman, nursing women.
Compare with injection, sterile freeze-drying preparation has good stability, transports the advantages such as more convenient.But the prescription of composite vitamin for injection lyophilized formulations, especially freeze-dry process, be that can sterile freeze-drying preparation finally form, with and the important factor in order of quality good or not.Developing the composite vitamin for injection lyophilized formulations that stability is high, impurity content is low is to need those skilled in the art to put forth effort the technical problem solving.
Summary of the invention
The invention provides a kind of composite vitamin for injection lyophilized formulations and preparation method thereof.In completing process of the present invention, inventor finds that different freeze-drying curves is huge to the quality influence of this product; In addition, even if choose optimized freeze-drying curve, in the present invention, the different order of addition of each component of lyophilized formulations in layoutprocedure also can produce different impacts to final product quality.Inventor, by the collocation method of different lyophilizing parameters and lyophilized formulations has been carried out to a large amount of research and experiments, has finally completed the present invention.Composite vitamin for injection lyophilized formulations of the present invention has advantages of that stability is high, impurity content is low.
Particularly, the present invention relates to a kind of composite vitamin for injection lyophilized formulations, its prescription is as follows:
Figure BSA00000750798600031
The invention still further relates to a kind of preparation method of composite vitamin for injection lyophilized formulations, and the composite vitamin for injection lyophilized formulations that utilizes the method to prepare, described method is as follows:
1), after calcium disodium edetate 0.5g is dissolved in water, 0.22um filters;
2) in filtrate, add 60% amount water for injection;
3) add vitamin C 200g, with sodium bicarbonate, regulate pH value to 5.0;
4) add successively glycine 300g, vitamin B 110g and in the riboflavin sodium phosphate 5g of riboflavin, regulates pH value to 5.0 with sodium bicarbonate;
5) 0.22um filters;
6) water for injection adds to 3000ml, and 0.22um filters, with 1000 bottles of the amount fills of 3ml/ bottle;
7) lyophilization.
Wherein, lyophilization step step 7) is as follows:
A) pre-freeze: goods cartonning, treat that sample temperature is down to-40 ℃, be warming up to-15 ℃~-20 ℃, preferably 40~50 ℃/h of heating rates, more preferably 40 ℃/h, make sample temperature be down to-45 ℃ following after, be incubated 3 hours;
B) evacuation: pre-freeze is finished, starts condenser refrigeration, is down to below-50 ℃, opens vacuum pump, makes freeze drying box vacuum be less than 0.15mba;
C) dry for the first time: after vacuum meets the requirements, start electrical heating, control and heat up, preferably 10~20 ℃/h of heating rates, more preferably 10 ℃/h, in-32 ℃ sublime up into sample below, watermark disappears, and is incubated 1~2 hour;
D) dry for the second time: control and be warming up to 30 ℃, preferably 8~10 ℃/h of heating rates,, are incubated 6 hours by more preferably 8 ℃/h;
E) tamponade, air inlet outlet, rolls mouth with aluminium-plastic combined cover.
In addition, the invention still further relates to described composite vitamin for injection lyophilized formulations and treat and/or prevent the purposes in avitaminosis in preparation.
The present invention, by rational material addition sequence, has avoided influencing each other between various vitamin, has increased the stability of product.The change (seeing embodiment 9~10) of material addition sequence in composite vitamin for injection lyophilized formulations prescription of the present invention, (seeing embodiment 11) obviously raises the impurity content that makes preparation of the present invention.Meanwhile, lyophilization step is on the impact of formulation products quality of the present invention also highly significant.The preferred freeze-drying curve of the present invention (seeing embodiment 2~4) can make product appearance smooth, color even is consistent, residual moisture content is qualified, good stability, can long term storage, make effectiveness and the safety of medicine obtain sound assurance, particularly the prescription of embodiment 3 and preparation technology have obtained optimum product.
The specific embodiment
Following embodiment, only for further illustrating the present invention, should not be interpreted as any limitation of the invention.
All medicines and the reagent that the present invention relates to are commercial.
Embodiment 1 composite vitamin for injection lyophilized formulations
Prescription:
Figure BSA00000750798600041
Preparation technology: get calcium disodium edetate 0.5g, 100 times of water gagings that add about calcium disodium edetate dissolve, 60 ℃ of stirrings of active carbon of solubilization dosage 0.05% 15 minutes, filter carbon removal, with 0.22 μ m membrane filtration, add the water for injection of total amount 60%, by prescription, measure vitamin C and add dissolving, gradation adds appropriate sodium bicarbonate, makes the pH value of solution maintain 5.0.Until the carbon dioxide ease of solution, to the greatest extent not during gassing, by recipe quantity, add glycine, vitamin B1 and riboflavin sodium phosphate, be stirred to dissolve, with manganese hydrogen sodium regulating solution pH value to 5.0 left and right, add the needle-use activated carbon of 0.05% (w/v), stir, the de-charcoal of coarse filtration after standing 15 minutes, benefit injects water to enough, checks now pH value and the content of product, qualified after, after 0.22 μ m filters, every bottle of about 3ml of fill, adds half plug, lyophilization:
A) pre-freeze: goods cartonning, treat that sample temperature is down to-40 ℃, be warming up to-10 ℃ (heating rate is 50 ℃/h), start compressor, make sample temperature be down to-45 ℃ following after, be incubated 3 hours;
B) evacuation: pre-freeze is finished, starts condenser refrigeration, is down to below-50 ℃, opens vacuum pump, makes freeze drying box vacuum be less than 0.15mba;
C) dry for the first time: after vacuum meets the requirements, start electrical heating, control and heat up (heating rate is 10 ℃/h), in-32 ℃ sublime up into sample below, watermark disappears, and is incubated 2 hours;
D) dry for the second time: to control and be warming up to 30 ℃ (heating rate is 10 ℃/h), be incubated 6 hours;
E) tamponade, air inlet outlet, rolls mouth with aluminium-plastic combined cover.
Embodiment 2 composite vitamin for injection lyophilized formulations
Preparation technology outside prescription and lyophilization is with embodiment 1, and difference is in lyophilization step:
A) pre-freeze: goods cartonning, treat that sample temperature is down to-40 ℃, be warming up to-15 ℃ (heating rate is 50 ℃/h), start compressor, make sample temperature be down to-45 ℃ following after, be incubated 3 hours;
B) evacuation: pre-freeze is finished, starts condenser refrigeration, is down to below-50 ℃, opens vacuum pump, makes freeze drying box vacuum be less than 0.15mba;
C) dry for the first time: after vacuum meets the requirements, start electrical heating, control and heat up (heating rate is 10 ℃/h), in-32 ℃ sublime up into sample below, watermark disappears, and is incubated 2 hours;
D) dry for the second time: to control and be warming up to 30 ℃ (heating rate is 10 ℃/h), be incubated 6 hours;
E) tamponade, air inlet outlet, rolls mouth with aluminium-plastic combined cover.
Embodiment 3 composite vitamin for injection lyophilized formulations
Preparation technology outside prescription and lyophilization is with embodiment 1, and difference is in lyophilization step:
A) pre-freeze: goods cartonning, treat that sample temperature is down to-40 ℃, be warming up to-20 ℃ (heating rate is 40 ℃/h), start compressor, make sample temperature be down to-45 ℃ following after, be incubated 3 hours;
B) evacuation: pre-freeze is finished, starts condenser refrigeration, is down to below-50 ℃, opens vacuum pump, makes freeze drying box vacuum be less than 0.15mba;
C) dry for the first time: after vacuum meets the requirements, start electrical heating, control and heat up (heating rate is 10 ℃/h), in-32 ℃ sublime up into sample below, watermark disappears, and is incubated 2 hours;
D) dry for the second time: to control and be warming up to 30 ℃ (heating rate is 8 ℃/h), be incubated 6 hours;
E) tamponade, air inlet outlet, rolls mouth with aluminium-plastic combined cover.
Embodiment 4 composite vitamin for injection lyophilized formulations
Preparation technology outside prescription and lyophilization is with embodiment 1, and difference is in lyophilization step:
A) pre-freeze: goods cartonning, treat that sample temperature is down to-40 ℃, be warming up to-20 ℃ (heating rate is 40 ℃/h), start compressor, make sample temperature be down to-45 ℃ following after, be incubated 3 hours;
B) evacuation: pre-freeze is finished, starts condenser refrigeration, is down to below-50 ℃, opens vacuum pump, makes freeze drying box vacuum be less than 0.15mba;
C) dry for the first time: after vacuum meets the requirements, start electrical heating, control and heat up (heating rate is 20 ℃/h), in-32 ℃ sublime up into sample below, watermark disappears, and is incubated 2 hours;
D) dry for the second time: to control and be warming up to 30 ℃ (heating rate is 10 ℃/h), be incubated 6 hours;
E) tamponade, air inlet outlet, rolls mouth with aluminium-plastic combined cover.
Embodiment 5 composite vitamin for injection lyophilized formulations (reference examples)
Preparation technology outside prescription and lyophilization is with embodiment 2, and difference is that lyophilization step heating rate a) is 50 ℃/h, step c) heating rate be 20 ℃/h, steps d) heating rate be 10 ℃/h.
Embodiment 6 composite vitamin for injection lyophilized formulations (reference examples)
Preparation technology outside prescription and lyophilization is with embodiment 3, and difference is that lyophilization step heating rate a) is 50 ℃/h, step c) heating rate be 10 ℃/h, steps d) heating rate be 8 ℃/h.
Embodiment 7 composite vitamin for injection lyophilized formulations (reference examples)
Preparation technology outside prescription and lyophilization is with embodiment 4, and difference is that lyophilization step heating rate a) is 40 ℃/h, step c) heating rate be 10 ℃/h, steps d) heating rate be 8 ℃/h.
Embodiment 8 composite vitamin for injection lyophilized formulations (reference examples)
Preparation technology outside prescription and lyophilization is with embodiment 3, and difference is that lyophilization step heating rate a) is 45 ℃/h, step c) heating rate be 10 ℃/h, steps d) heating rate be 8 ℃/h.
Embodiment 9 composite vitamin for injection lyophilized formulations (reference examples)
Prescription: with embodiment 1.
Preparation technology: get calcium disodium edetate 0.5g, add approximately 100 times of water dissolutioies, 60 ℃ of stirrings of active carbon of solubilization dosage 0.05% 15 minutes, filter carbon removal, with 0.22 μ m membrane filtration, add 60% water for injection, by recipe quantity, add glycine, vitamin B1 and riboflavin sodium phosphate, be stirred to dissolve, by prescription, measure vitamin C and add dissolving, gradation adds appropriate sodium bicarbonate, makes the pH value of solution maintain 5.0.Until the carbon dioxide ease of solution to the greatest extent not during gassing, with manganese hydrogen sodium regulating solution pH value to 5.0 left and right, add the needle-use activated carbon of 0.05% (w/v), stir, the de-charcoal of coarse filtration after standing 15 minutes, benefit injects water to enough, checks pH value and the content of intermediate, qualified after, after 0.22 μ m sterilizing filter membrane fine straining, every bottle of about 3ml of fill, adds half plug, lyophilization (lyophilization step is with embodiment 2).
Embodiment 10 composite vitamin for injection lyophilized formulations (reference examples)
Prescription: with embodiment 1.
Preparation technology: measure glycine, vitamin B1 and riboflavin sodium phosphate by prescription, adding water is stirred to dissolve, add calcium disodium edetate 0.5g, be stirred to dissolve, 60 ℃ of stirrings of active carbon of solubilization dosage 0.05% 15 minutes, filter carbon removal, with 0.22 μ m membrane filtration, add 60% water for injection, by prescription, measure vitamin C and add dissolving, gradation adds appropriate sodium bicarbonate, makes the pH value of solution maintain 5.0.Until the carbon dioxide ease of solution to the greatest extent not during gassing, with manganese hydrogen sodium regulating solution pH value to 5.0 left and right, add the needle-use activated carbon of 0.05% (w/v), stir, the de-charcoal of coarse filtration after standing 15 minutes, benefit injects water to enough, checks pH value and the content of intermediate, qualified after, after 0.22 μ m filters, every bottle of about 3ml of fill, adds half plug, lyophilization (lyophilization step is with embodiment 3).
The stability experiment of the composite vitamin for injection lyophilized formulations of embodiment 11 embodiment 1~10 preparations
According to composite vitamin for injection (3), declare quality standard, the composite vitamin for injection lyophilized formulations of embodiment 1~10 preparation is detected, result is as follows:
Table 1 stability experiment result (0 month)
Figure BSA00000750798600081
Table 2 stability experiment result (6 months, temperature: 40 ℃, humidity 75%)
Figure BSA00000750798600092
Figure BSA00000750798600101

Claims (7)

1. a composite vitamin for injection lyophilized formulations, its prescription is as follows:
2. a composite vitamin for injection lyophilized formulations described in claim 1, it is prepared as follows:
1), after calcium disodium edetate 0.5g is dissolved in water, 0.22um filters;
2) in filtrate, add 60% amount water for injection;
3) add vitamin C 200g, with sodium bicarbonate, regulate pH value to 5.0;
4) add successively glycine 300g, vitamin B 110g and in the riboflavin sodium phosphate 5g of riboflavin, regulates pH value to approximately 5.0 with sodium bicarbonate;
5) 0.22um filters;
6) water for injection adds to 3000ml, and 0.22um filters, with 1000 bottles of the amount fills of 3ml/ bottle;
7) lyophilization.
3. a preparation method for composite vitamin for injection lyophilized formulations described in claim 1, comprises the steps:
1), after calcium disodium edetate 0.5g is dissolved in water, 0.22um filters;
2) in filtrate, add 60% amount water for injection;
3) add vitamin C 200g, with sodium bicarbonate, regulate pH value to 5.0;
4) add successively glycine 300g, vitamin B 110g and in the riboflavin sodium phosphate 5g of riboflavin, regulates pH value to 5.0 with sodium bicarbonate;
5) 0.22um filters;
6) water for injection adds to 3000ml, and 0.22um filters, with 1000 bottles of the amount fills of 3ml/ bottle;
7) lyophilization.
4. method according to claim 3, wherein step 7) lyophilization step as follows:
A) pre-freeze: goods cartonning, treat that sample temperature is down to-40 ℃, be warming up to-15 ℃~-20 ℃, keep 30 minutes, cooling make sample temperature be down to-45 ℃ following after, be incubated 3 hours;
B) evacuation: pre-freeze is finished, starts condenser refrigeration, is down to below-50 ℃, opens vacuum pump, makes freeze drying box vacuum be less than 0.15mba;
C) dry for the first time: after vacuum meets the requirements, start electrical heating, control and heat up, in-32 ℃ sublime up into sample below, watermark disappears, and is incubated 1~2 hour;
D) dry for the second time: to control and be warming up to 30 ℃, be incubated 6 hours;
E) tamponade, air inlet outlet, rolls mouth with aluminium-plastic combined cover.
5. method according to claim 4, wherein step heating rate a) is 40~50 ℃/h, step c) heating rate be 10~20 ℃/h, steps d) heating rate be 8~10 ℃/h.
6. method according to claim 4, wherein step heating rate a) is 40 ℃/h, step c) heating rate be 10 ℃/h, steps d) heating rate be 8 ℃/h.
7. the preparation described in claim 1 or 2 treats and/or prevents the purposes in avitaminosis in preparation.
CN201210248472.XA 2012-07-18 2012-07-18 Compound vitamin lyophilized preparation for injection and its preparation method Active CN103565811B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210248472.XA CN103565811B (en) 2012-07-18 2012-07-18 Compound vitamin lyophilized preparation for injection and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210248472.XA CN103565811B (en) 2012-07-18 2012-07-18 Compound vitamin lyophilized preparation for injection and its preparation method

Publications (2)

Publication Number Publication Date
CN103565811A true CN103565811A (en) 2014-02-12
CN103565811B CN103565811B (en) 2014-08-20

Family

ID=50039093

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210248472.XA Active CN103565811B (en) 2012-07-18 2012-07-18 Compound vitamin lyophilized preparation for injection and its preparation method

Country Status (1)

Country Link
CN (1) CN103565811B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104490902A (en) * 2014-12-30 2015-04-08 李迪 Compound vitamin lyophilized powder injection composition for injection and preparation method thereof
CN108815166A (en) * 2018-08-16 2018-11-16 济南康和医药科技有限公司 A kind of Compound vitamine injection and preparation method thereof
CN109364082A (en) * 2018-06-08 2019-02-22 河北爱尔海泰制药有限公司 A kind of high stability composite vitamin for injection lyophilized preparation composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623293A (en) * 2009-08-20 2010-01-13 北京普瑞博思投资有限公司 Medical composition for injection
CN102552294A (en) * 2012-01-10 2012-07-11 辽宁海思科制药有限公司 Compound vitamin (3) freeze-dried powder injection for injection and preparation method and analysis method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623293A (en) * 2009-08-20 2010-01-13 北京普瑞博思投资有限公司 Medical composition for injection
CN102552294A (en) * 2012-01-10 2012-07-11 辽宁海思科制药有限公司 Compound vitamin (3) freeze-dried powder injection for injection and preparation method and analysis method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
易建勇: "注射用十二种复合维生素的冻干曲线研究", 《今日药学》, vol. 20, no. 3, 31 March 2010 (2010-03-31), pages 25 - 27 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104490902A (en) * 2014-12-30 2015-04-08 李迪 Compound vitamin lyophilized powder injection composition for injection and preparation method thereof
CN109364082A (en) * 2018-06-08 2019-02-22 河北爱尔海泰制药有限公司 A kind of high stability composite vitamin for injection lyophilized preparation composition
CN108815166A (en) * 2018-08-16 2018-11-16 济南康和医药科技有限公司 A kind of Compound vitamine injection and preparation method thereof

Also Published As

Publication number Publication date
CN103565811B (en) 2014-08-20

Similar Documents

Publication Publication Date Title
US6399114B2 (en) Nutritional system for nervous system disorders
CN101583351A (en) Nutritional supplement composition for treatment of ocular diseases
CN103565811B (en) Compound vitamin lyophilized preparation for injection and its preparation method
CN101181289A (en) Injection of 13 kinds complex vitamin and preparing technique thereof
CN113632848A (en) Children milk powder beneficial to bone growth and preparation method thereof
CN102512437B (en) Medicinal composition of liposoluble vitamin injection (I) and water-soluble vitamin for injection and preparation method thereof
JP2007209324A (en) Method for producing iron supplement composition
EP1633377B1 (en) A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein
CN110122707A (en) One kind is relieved the effect of alcohol fruit drink and preparation method thereof
JPWO2008123298A1 (en) Infusion formulation for cancer patients
JP4011638B2 (en) Oral enteral nutrition composition
US6423309B1 (en) Composition containing grass plant, water-soluble dietary fibers, oligosaccharides, lactic acid bacteria and green tea
CN103385889B (en) Carbohydrate and electrolyte mixed injection and preparation method thereof
KR20190105737A (en) A infusion solution containing fat-soluble vitamins and trace elements
CN107712909A (en) A kind of iron zinc Muti-vitamine Oral Solution
TWI403276B (en) Nutritional composition for wound healing
CN103169756B (en) Pharmaceutical composition of water-soluble vitamins for injection, fat-soluble vitamin injection and fat emulsion injection
CN109770365A (en) One kind of multiple chewable vitamin tablets and preparation method thereof
CN102499939A (en) Pharmaceutical compositions of fat-soluble vitamins for injection and water-soluble vitamins for injection and preparation method thereof
CN102397250A (en) Aqueous vitamin liposome for injection and preparation method thereof
CN109481459A (en) A kind of compound electrolyte glucose injection and preparation method thereof
CN115153033A (en) Compound small molecule peptide formula for conditioning body nutrition imbalance
CN114747720A (en) Soybean peptide composite powder composition combined powder and preparation method thereof
CN103169755B (en) Pharmaceutical composition of water-soluble vitamins for injection, fat-soluble vitamins for injection and fat emulsion injection
CN107510701B (en) A kind of children mend the composition and its preparation method and application of iron and vitamin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190827

Address after: 050035 Taishan Street 219, Shijiazhuang High-tech Industrial Development Zone, Hebei Province

Patentee after: Hebei Ideal & Hightech Pharmaceutical Co., Ltd.

Address before: 050035 No. 219, Taishan street, hi tech Industrial Development Zone, Hebei, Shijiazhuang

Patentee before: Hebei Zhitong Pharmaceutical Group Co., Ltd.

TR01 Transfer of patent right